Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Pediatrics"
DOI: 10.1542/peds.2016-3148
Abstract: Tocilizumab profoundly improved the inflammatory features of PHID and thus may be beneficial for PHID-associated autoinflammation. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) is associated with recessive mutations in SLC29A3, encoding the equilibrative nucleoside… read more here.
Keywords: autoinflammation; phid syndrome; phid; tocilizumab treatment ... See more keywords